Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc. on September 27, 2023. Cosmos Health has determined that spinning off its R&D division into a standalone, well-capitalized, publicly listed biotech entity will best serve its shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.65 USD | +25.75% | +34.35% | -53.90% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.90% | 10.95M | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
-5.62% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- COSM Stock
- News Cosmos Health Inc.
- Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc.